Lung Opacity Diagnosis and Management

Introduction to Lung Opacity

The American College of Chest Physicians recommends considering a broad spectrum of pathologic processes that replace air in the alveoli or interstitium as causes of lung opacities, with the most common being pneumonia, pulmonary edema, drug-related pneumonitis, interstitial lung diseases, and malignancy, each requiring distinct treatment approaches based on the specific underlying etiology 1, 2

The American Thoracic Society suggests that high-resolution computed tomography (HRCT) is superior for characterizing opacity patterns and extent, and can help identify the underlying cause of lung opacity 1, 3
The use of ultrasound chest detects pleural effusions and consolidation with 92-93% sensitivity, superior to chest X-ray, as recommended by the American College of Emergency Physicians 2

Isolated GGO without fibrotic features indicates inflammatory cells in the alveolar septum or lumen (alveolitis), according to the Fleischner Society 3
GGO with reticular lines and traction bronchiectasis indicates established lung fibrosis, as stated by the American Thoracic Society 3

Infectious/inflammatory pneumonia presents as patchy or diffuse opacities with fever, productive cough, leukocytosis, and oxygen desaturation <92%, and immediate management involves initiating empiric antibiotics without waiting for culture results, as recommended by the Infectious Diseases Society of America 2
Drug-related pneumonitis from molecular targeting agents and immune checkpoint inhibitors presents with various interstitial patterns, with organizing pneumonia (OP) being most common (23%), followed by hypersensitivity pneumonitis (HP) pattern (16%), according to the American Society of Clinical Oncology 4

Idiopathic pulmonary fibrosis (IPF) may show GGOs, but extensive ground glass opacity (>30% of lung involvement) should prompt consideration of alternative diagnoses, as stated by the American Thoracic Society 1, 3
Nonspecific interstitial pneumonia (NSIP) frequently presents with GGOs without basal or peripheral predominance, according to the American College of Chest Physicians 1, 3

Corticosteroid therapy is the primary treatment for most patterns of drug-related pneumonitis, as recommended by the American Society of Clinical Oncology 4
Corticosteroid therapy results in clinical recovery in two-thirds of patients with organizing pneumonia (OP), according to the American Thoracic Society 5, 6

The extent of GGOs on CT correlates with physiologic impairment and can help predict response to treatment, as stated by the Fleischner Society 1, 3
GGOs may progress to reticular opacity or honeycombing on follow-up in fibrotic processes, according to the American Thoracic Society 1, 3